Home > Healthcare & Medical Devices > Aesthetic Medicine Market

Aesthetic Medicine Market Size By Type (Non-surgical, Surgical), By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI2687
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Aesthetic Medicine Market size was recorded at more than USD 16.5 billion 2022. Driven by surging patient demand for non-invasive procedures, the industry is expected to grow at over 18.5% CAGR from 2023 to 2032.
 

The mounting popularity of aesthetic procedures due to various standards of appearance is speculated to foster market progress. Moreover, an upsurge in the population base aged between 30-65 years is also foreseen to bolster the demand for aesthetic procedures in the coming period.
 

Get more details on this report - Request Free Sample PDF
 

Unhealthy lifestyle choices and monotonous eating patterns among people have resulted in snowballing cases of obesity, providing lucrative opportunities for aesthetic medicine industry expansion. According to the Centers for Disease Control and Prevention (CDC), more than 50.4% of the U.S. population was suffering from obesity in 2022, affecting millions of people in the country. Aesthetic medicine or procedures improve the physical appearance and satisfaction of the patient using minimally invasive tools, and is thus, gaining popularity in developed and developing economies.
 

Expensiveness of aesthetic procedures may restrain industry progression

The high cost associated with aesthetic procedures is a major factor restraining aesthetic medicine market development. These cosmetic procedures are comparatively expensive and unaffordable for low- and middle-income populations, especially in developing economies. The procedure consists of high-power lasers or liposuction devices, which require considerable capital investment. Nonetheless, continuous efforts by private and public organizations to minimize the complexity of procedures are poised to aid the market value.
 

Surging demand for facial surgeries to push market share

Get more details on this report - Request Free Sample PDF
 

In terms of type, the aesthetic medicine market is categorized into non-surgical and surgical. The surgical segment is primed to progress at an 18% CAGR from 2023 to 2032. The soaring demand for facial aesthetic surgeries, such as eyelid & nose reshaping surgery and hair transplantation, is accelerating the uptake of aesthetic medicine. In addition, mounting awareness among people regarding aesthetic procedures is also positively impacting the surgical procedures segment outlook.
 

Soaring demand for economical treatments to help non-energy-based aesthetic medicine gain traction

With respect to products, the aesthetic medicine market is divided into energy-based and non-energy-based. The non-energy-based segment was valued at more than USD 12.5 billion in 2022. Technological advancements in non-energy-based medical aesthetic devices to offer convenient, effective, and less invasive treatments, which include a varied range of products from injectables to implants, are expected to drive the segment’s progress.
 

Consistent developments in procedures to augment male segment revenues

Based on gender, the aesthetic medicine market is classified into male and female. As per the report, the male segment garnered over 20% business share in 2022 on account of consistent technological advancements in male aesthetic procedures, such as PRP hair rejuvenation therapies, gynecomastia, and body sculpting procedures. This has influenced the inclination of the male population towards non-invasive/minimally invasive procedures, thereby leading to the high adoption of cosmetic procedures.
 

Availability of minimally invasive procedures to favor ambulatory surgical centers segment

Get more details on this report - Request Free Sample PDF
 

In terms of end-use, the aesthetic medicine market is segregated into hospitals, beauty centers & medical spas, ambulatory surgical centers, dermatology clinics, and home settings. The ambulatory surgical centers segment is anticipated to expand at a 19.5% CAGR over the next 10 years. This is attributable to the shifting preference of people toward ambulatory surgical centers as they provide minimally invasive procedures. Furthermore, various factors such as shorter stays, cost-effective procedures, and reduced risk of hospital-acquired infections in these facilities are attracting patients to ambulatory surgical centers.
 

Soaring investments to aid Asia Pacific emerge as a prominent revenue pocket

Get more details on this report - Request Free Sample PDF
 

Asia Pacific aesthetic medicine market is projected to reach more than USD 13.5 billion by 2032. The region is likely to observe significant investments by public and private organizations to increase awareness regarding improving beauty standards, which is foreseen to propel product adoption. Additionally, surging efforts by market players to capture a high market share in the APAC countries are slated to augment the industry expansion.
 

R&D initiatives to strengthen the market outlook

Allergan, Syneron Candela, Galderma, Lumenis, Inc, Alma Lasers, Merz Pharmaceuticals, Johnson & Johnson, Cutera, Inc., PhotoMedex, Bausch Health Companies, Inc., and Cynosure are some key aesthetic medicine industry players. These companies majorly focus on innovating solutions and services to remain ahead in the competitive landscape.
 

Impact of COVID-19 on the aesthetic medicine market trends

During the COVID-19 pandemic, the industry witnessed a setback in terms of supply operation as a result of the widespread risk of cross-contamination while conducting procedures. Safety concerns associated with aesthetic procedures hampered the market outlook. The need for various procedures, including hair reduction, scar treatment, facial rejuvenation procedures, and skin tightening, declined drastically. However, few procedures showcased tremendous demand, including dermal fillers which helped in maintaining the market momentum up to some extent.
 

The aesthetic medicine market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

By Type

  • Non-surgical
  • Surgical

By Application

  • Energy-based
    • Laser-based aesthetic device
    • Radiofrequency (RF)-based aesthetic device
    • Light-based aesthetic device
    • Ultrasound aesthetic device
    • Others
  • Non-energy-based
    • Botulinum toxin
    • Dermal fillers
    • Implants
      • Facial implants
      • Breast implants
      • Others

By Gender

  • Male
    • 18 Years and Below
    • 19-34 Years
    • 35-50 Years
    • 51-64 Years
    • 65 Years and Above
  • Female
    • 18 Years and Below
    • 19-34 Years
    • 35-50 Years
    • 51-64 Years
    • 65 Years and Above

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Beauty Centers & Medical Spas
  • Dermatology Clinics
  • Home Settings

 

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Others

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for aesthetic medicine was valued at more than USD 16.5 billion in 2022 and is set to progress at over 18.5% CAGR over the next 10 years owing to the mounting popularity of aesthetic procedures due to prevalent beauty standards and surging patient demand for non-invasive procedures.
Ambulatory surgical centers segment is anticipated to expand at a 19.5% CAGR over 2023-2032 due to soaring patient preference for shorter stays, cost-effective procedures, and reduced risk of hospital-acquired infections in these facilities.
Non-energy-based segment was valued at more than USD 12.5 billion in 2022 as a result of ongoing technological advancements in non-energy-based medical aesthetic devices intended to offer convenient, effective, and less invasive treatments.
Asia Pacific aesthetic medicine market is projected to reach more than USD 13.5 billion by 2032 as a result of increasing awareness regarding improving beauty standards in the APAC region.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 486
  • Countries covered: 16
  • Pages: 201
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount